EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Survival advantage of conversion surgery following induction therapy in cT4 esophageal cancer: A systematic review and meta-analysis

Kai-Yuan Jiang, Lu-Dan Zhang, Ai-Ling Zhong, Wen-Long Hu, Jun-Jie Wang, Jun-Jie Zhang, Yu-Yang Mao, Zhi-Qiang Deng, Dong Tian

European Journal of Surgical Oncology · 2026-06 · 52 (6) · 111806

DOI: 10.1016/j.ejso.2026.111806 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift European Journal of Surgical Oncology, 2026-06. Verfasst von Kai-Yuan Jiang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, 610041, China; Department of Surgery, Tohoku University Graduate Sc…. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Esophagectomy, Chemoradiotherapy. Die Arbeit nennt 57 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND cT4 esophageal cancer represents a major therapeutic challenge, with definitive chemoradiotherapy (dCRT) currently considered the standard treatment. However, survival outcomes remain unsatisfactory. CS following induction therapy has emerged as a potential alternative strategy, though its clinical effectiveness remains under debate. This systematic review and meta-analysis aimed to compare survival outcomes between conversion surgery (CS) and definitive therapy in patients with cT4 esophageal cancer. METHODS Relevant literature was retrieved from PubMed, the Cochrane Library, and Embase. Patients were categorized into the CS group or the definitive therapy group. A systematic review and meta-analysis were performed to evaluate 1-, 3-, and 5-year overall survival (OS) outcomes in patients with esophageal cancer. Odds ratios, mean differences, and 95% confidence intervals were calculated using fixed-effects or random-effects models. RESULTS Seventeen studies involving a total of 3721 patients with cT4 esophageal cancer were included. After excluding studies with high heterogeneity, CS was associated with significantly better survival compared to definitive therapy at 1-year (73.6% vs. 49.6%), 3-year (37.0% vs. 18.4%), and 5-year (26.5% vs. 11.6%) OS. A subgroup analysis of three studies including 341 patients with cT4b disease revealed a significant survival advantage for the CS group in both 1-year OS (86.4% vs. 37.6%) and 3-year OS (48.6% vs. 11.4%). CONCLUSIONS CS following induction therapy significantly improves survival in patients with cT4 esophageal cancer. However, the survival benefit of CS for cT4b disease requires further validation in larger prospective studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal NeoplasmsEsophagectomyChemoradiotherapyHumansNeoplasm StagingInduction ChemotherapySurvival RateNeoadjuvant Therapy

Stichwörter der Autor:innen

Conversion surgeryEsophageal cancerInduction therapyT4

Autor:innen und Institutionen

  • Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, 610041, China; Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, 980-8575, Japan.
  • College of Clinical Medicine, North Sichuan Medical College, Nanchong, 637000, China.
  • College of Medical Imaging, North Sichuan Medical College, Nanchong, 637000, China.
  • Department of Thoracic Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China.
  • Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, 610041, China. Electronic address: 22tiandong@wchscu.cn.

Zitieren

APA

Jiang, K. Y., Zhang, L. D., Zhong, A. L., Hu, W. L., Wang, J. J., Zhang, J. J., Mao, Y. Y., Deng, Z. Q., & Tian, D. (2026). Survival advantage of conversion surgery following induction therapy in cT4 esophageal cancer: A systematic review and meta-analysis. European Journal of Surgical Oncology, 52(6), 111806. https://doi.org/10.1016/j.ejso.2026.111806

Vancouver

Jiang KY, Zhang LD, Zhong AL, Hu WL, Wang JJ, Zhang JJ, et al. Survival advantage of conversion surgery following induction therapy in cT4 esophageal cancer: A systematic review and meta-analysis. European Journal of Surgical Oncology. 2026;52(6):111806. doi:10.1016/j.ejso.2026.111806

BibTeX
@article{Jiang2026,
  author = {Jiang, Kai-Yuan and Zhang, Lu-Dan and Zhong, Ai-Ling and Hu, Wen-Long and Wang, Jun-Jie and Zhang, Jun-Jie and Mao, Yu-Yang and Deng, Zhi-Qiang and Tian, Dong},
  title = {Survival advantage of conversion surgery following induction therapy in cT4 esophageal cancer: A systematic review and meta-analysis},
  journal = {European Journal of Surgical Oncology},
  year = {2026},
  volume = {52},
  number = {6},
  pages = {111806},
  doi = {10.1016/j.ejso.2026.111806}
}
Kostenlos starten →